{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:22:54Z","timestamp":1789906974204,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Diagnostics and Technology Branch of the Australian Government Department of Health and Ageing","award":["501106"],"award-info":[{"award-number":["501106"]}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["300705"],"award-info":[{"award-number":["300705"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["455521"],"award-info":[{"award-number":["455521"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1006447"],"award-info":[{"award-number":["1006447"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001081","name":"Hunter Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001081","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Research Council"},{"DOI":"10.13039\/501100000774","name":"University of Newcastle","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000774","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100013027","name":"Calvary Mater Newcastle","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013027","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Novartis Pharmaceuticals"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.radonc.2015.10.003","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T17:27:58Z","timestamp":1445707678000},"page":"277-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Urinary symptoms following external beam radiotherapy of the prostate: Dose\u2013symptom correlates with multiple-event and event-count models"],"prefix":"10.1016","volume":"117","clinical-trial-number":[{"clinical-trial-number":"nct00193856","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2736-6489","authenticated-orcid":false,"given":"Noorazrul","family":"Yahya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A.","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Bulsara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"House","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Denham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2015.10.003_b0005","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.ijrobp.2009.02.090","article-title":"Radiation dose\u2013volume effects of the urinary bladder","volume":"76","author":"Viswanathan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.10.003_b0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.radonc.2014.02.006","article-title":"Relationships between bladder dose\u2013volume\/surface histograms and acute urinary toxicity after radiotherapy for prostate cancer","volume":"111","author":"Carillo","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.10.003_b0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijrobp.2009.07.1680","article-title":"Urinary obstruction in prostate cancer patients from the Dutch trial (68 Gy vs. 78 Gy): relationships with local dose, acute effects, and baseline characteristics","volume":"78","author":"Heemsbergen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.10.003_b0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2014.04.005","article-title":"Integrated models for the prediction of late genitourinary complaints after high-dose intensity modulated radiotherapy for prostate cancer: making informed decisions","volume":"112","author":"De Langhe","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.10.003_b0025","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ijrobp.2007.04.076","article-title":"Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose\u2013volume analysis of a phase II dose-escalation study","volume":"69","author":"Harsolia","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.10.003_b0030","doi-asserted-by":"crossref","DOI":"10.1007\/s00345-013-1146-8","article-title":"Nomograms to predict late urinary toxicity after prostate cancer radiotherapy","author":"Mathieu","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.radonc.2015.10.003_b0035","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ijrobp.2006.10.042","article-title":"Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer","volume":"67","author":"Cheung","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.10.003_b0040","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0360-3016(99)00443-5","article-title":"Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG\/RTOG 9406","volume":"46","author":"Michalski","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.10.003_b0045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.eururo.2010.03.014","article-title":"Urinary incontinence, overactive bladder, and other lower urinary tract symptoms: a longitudinal population-based survey in men aged 45\u2013103 years","volume":"58","author":"Malmsten","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.radonc.2015.10.003_b0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.radonc.2005.10.005","article-title":"Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation","volume":"77","author":"Christie","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.10.003_b0055","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2012.05.007","article-title":"Late gastrointestinal and urogenital side-effects after radiotherapy-incidence and prevalence. Subgroup-analysis within the prospective Austrian-German phase II multicenter trial for localized prostate cancer","volume":"104","author":"Schmid","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.10.003_b0060","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ijrobp.2010.03.040","article-title":"External beam radiotherapy for prostate cancer: urinary outcomes for men with high International Prostate Symptom Scores (IPSS)","volume":"80","author":"Malik","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.10.003_b0065","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.eururo.2013.02.001","article-title":"Patterns and predictors of amelioration of genitourinary toxicity after high-dose intensity-modulated radiation therapy for localized prostate cancer: implications for defining postradiotherapy urinary toxicity","volume":"64","author":"Ghadjar","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.radonc.2015.10.003_b0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.radonc.2010.08.002","article-title":"The relationship between external beam radiotherapy dose and chronic urinary dysfunction \u2013 a methodological critique","volume":"97","author":"Rosewall","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.10.003_b0075","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijrobp.2011.06.1953","article-title":"Late fecal incontinence after high-dose radiotherapy for prostate cancer: better prediction using longitudinal definitions","volume":"83","author":"Fiorino","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.10.003_b0080","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.radonc.2009.12.019","article-title":"A comparison of dose\u2013volume constraints derived using peak and longitudinal definitions of late rectal toxicity","volume":"94","author":"Gulliford","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.10.003_b0085","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.radonc.2008.09.019","article-title":"Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial","volume":"90","author":"Capp","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.10.003_b0090","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S1470-2045(14)70328-6","volume":"15","author":"Denham","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2015.10.003_b0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.radonc.2015.05.016","article-title":"Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial","volume":"115","author":"Denham","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.10.003_b0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.radonc.2008.10.011","article-title":"Assuring high quality treatment delivery in clinical trials \u2013 results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 \u201cRADAR\u201d set-up accuracy study","volume":"90","author":"Haworth","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.10.003_b0105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/1754-9485.12025","article-title":"Quality improvements in prostate radiotherapy: outcomes and impact of comprehensive quality assurance during the TROG 03.04 \u2018RADAR\u2019 trial","volume":"57","author":"Kearvell","year":"2013","journal-title":"J Med Imag Radiat Oncol"},{"key":"10.1016\/j.radonc.2015.10.003_b0110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.radonc.2007.11.013","article-title":"Detailed review and analysis of complex radiotherapy clinical trial planning data: evaluation and initial experience with the SWAN software system","volume":"86","author":"Ebert","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.10.003_b0115","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.radonc.2012.10.006","article-title":"Bioeffect modeling and equieffective dose concepts in radiation oncology\u2013terminology, quantities and units","volume":"105","author":"Bentzen","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.10.003_b0120","doi-asserted-by":"crossref","first-page":"N337","DOI":"10.1088\/0031-9155\/55\/11\/N04","article-title":"Comparison of DVH data from multiple radiotherapy treatment planning systems","volume":"55","author":"Ebert","year":"2010","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2015.10.003_b0125","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1088\/0031-9155\/50\/15\/007","article-title":"Absolute and relative dose-surface and dose\u2013volume histograms of the bladder: which one is the most representative for the actual treatment?","volume":"50","author":"Hoogeman","year":"2005","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2015.10.003_b0130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1118\/1.598063","article-title":"Reporting and analyzing dose distributions: a concept of equivalent uniform dose","volume":"24","author":"Niemierko","year":"1997","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2015.10.003_b0135","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0360-3016(95)90159-0","article-title":"LENT SOMA scales for all anatomic sites","volume":"31","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.10.003_b0140","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/aje\/kwf215","article-title":"Statistical analysis of correlated data using generalized estimating equations: an orientation","volume":"157","author":"Hanley","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.radonc.2015.10.003_b0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/00223890802634175","article-title":"The analysis of count data: a gentle introduction to poisson regression and its alternatives","volume":"91","author":"Coxe","year":"2009","journal-title":"J Pers Assess"},{"key":"10.1016\/j.radonc.2015.10.003_b0150","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1464-5491.2004.01250.x","article-title":"Evaluating risk factors associated with severe hypoglycaemia in epidemiology studies \u2013 what method should we use?","volume":"21","author":"Bulsara","year":"2004","journal-title":"Diabetic Med"},{"key":"10.1016\/j.radonc.2015.10.003_b0155","series-title":"R: a language and environment for statistical computing","isbn-type":"print","year":"2013","ISBN":"https:\/\/id.crossref.org\/isbn\/3900051070"},{"key":"10.1016\/j.radonc.2015.10.003_b0160","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.radonc.2012.09.018","article-title":"Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer","volume":"105","author":"Denham","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.10.003_b0165","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.radonc.2015.06.011","article-title":"Dosimetry, clinical factors and medication intake influencing urinary symptoms after prostate radiotherapy: an analysis of data from the RADAR prostate radiotherapy trial","volume":"116","author":"Yahya","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.10.003_b0170","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/00031305.1990.10475712","article-title":"Multiple comparison procedures \u2013 the practical solution","volume":"44","author":"Saville","year":"1990","journal-title":"Am Stat"},{"key":"10.1016\/j.radonc.2015.10.003_b0175","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.radonc.2015.10.003_b0180","first-page":"349","article-title":"Perceptions of urinary symptoms and health-care-seeking behaviour amongst men aged 40\u201379 years","volume":"46","author":"Cunningham-Burley","year":"1996","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.radonc.2015.10.003_b0185","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.radonc.2013.11.011","article-title":"The impact of gastrointestinal and genitourinary toxicity on health related quality of life among irradiated prostate cancer patients","volume":"110","author":"Schaake","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.10.003_b0190","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0360-3016(94)00431-J","article-title":"The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy","volume":"31","author":"Marks","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.10.003_b0195","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0360-3016(91)90172-Z","article-title":"Fitting of normal tissue tolerance data to an analytic function","volume":"21","author":"Burman","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.10.003_b0200","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.10.003_b0205","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.radonc.2011.01.006","article-title":"Does the planning dose\u2013volume histogram represent treatment doses in image-guided prostate radiation therapy? Assessment with cone-beam computerised tomography scans","volume":"98","author":"Hatton","year":"2011","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814015005459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814015005459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T23:55:59Z","timestamp":1718150159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814015005459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0167814015005459"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2015.10.003","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary symptoms following external beam radiotherapy of the prostate: Dose\u2013symptom correlates with multiple-event and event-count models","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2015.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}